Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia.

Journal article

Xue K. et al, (2018), Nat Med, 24, 1507 - 1512

Choroideremia: molecular mechanisms and development of AAV gene therapy.

Journal article

Patrício MI. et al, (2018), Expert Opin Biol Ther, 18, 807 - 820

The Biological Activity of AAV Vectors for Choroideremia Gene Therapy Can Be Measured by In Vitro Prenylation of RAB6A.

Journal article

Patrício MI. et al, (2018), Mol Ther Methods Clin Dev, 9, 288 - 295

Retinal Degeneration in Choroideremia follows an Exponential Decay Function.

Journal article

Aylward JW. et al, (2018), Ophthalmology

Human Retinal Explant Culture for Ex Vivo Validation of AAV Gene Therapy.


Orlans HO. et al, (2018), 1715, 289 - 303

Novel non-contiguous exon duplication in choroideremia.

Journal article

Edwards TL. et al, (2018), Clin Genet, 93, 144 - 148

Prenylation of Rab6a as a Potency Assay for Choroideremia Gene Therapy

Journal article

Patricio MI. et al, (2017), MOLECULAR THERAPY, 25, 142 - 143

Acetylated bacterial cellulose coated with urinary bladder matrix as a substrate for retinal pigment epithelium.

Journal article

Gonçalves S. et al, (2016), Colloids Surf B Biointerfaces, 139, 1 - 9

Rab11b mediates melanin transfer between donor melanocytes and acceptor keratinocytes via coupled exo/endocytosis.

Journal article

Tarafder AK. et al, (2014), J Invest Dermatol, 134, 1056 - 1066